Safe subdural administration and retention of a neurotrophin-3-delivering hydrogel in a rat model of spinal cord injury

Authors
Meissner, Svenja, Lopez, Salvador, Rees, Shaun, O'Carroll, Simon, Barker, David, Harland, Bruce, Raos, Brad, Svirskis, Darren


Lab

Journal
Scientific Reports

Abstract
Neurotrophic growth factor (GF) loaded hydrogels have shown promise as a treatment approach for spinal cord injury (SCI). However, SCI presents complex challenges for the direct administration of treatment due to the spinal cord's intricate anatomy and highly sensitive environment. Many current hydrogel administration approaches overlook this complexity, limiting their translational potential. To address this, we propose a novel intrathecal administration method using an in situ gelling, hyaluronic acid-modified heparin-poloxamer hydrogel loaded with neurotrophin-3 (NT-3) for the direct delivery of NT-3 to the spinal cord. We injected a NT-3 loaded hydrogel into the intrathecal space immediately after contusion SCI in Sprague Dawley (SpD) rats. Our results indicate that injecting the NT-3 loaded hydrogel into the intrathecal space was safe and that the gel was retained alongside the cord for at least one week. Additionally, no adverse effects were observed on rat behaviour. While functional improvement trends were noted, statistical significance was not reached, and immunohistochemistry results showed no significant difference between treatment groups. Overall, our findings suggest the feasibility, safety, and potential of the developed intrathecal administration technique for delivering diverse therapeutic molecules for SCI recovery.

Keywords/Topics
Sustained release ;Poloxamer hydrogel ;Tissue engineering; Intrathecal delivery ;Sprague Dawley rats ;Growth factors; Subjects Biomaterials; Neurotrophic factors ;Spinal cord diseases

BIOSEB Instruments Used:
Modular holder cages for rats and mice (BIO-PVF)

Source :

https://www.nature.com/articles/s41598-024-77423-5

Publication request

Thank you for your interest in our product range and your request for this publication, which will be sent to you if the research team and the journal allow it. Our commercial team will contact you as soon as possible.